New hope for breast cancer in the liver: targeted chemo combo enters trial
NCT ID NCT06875128
First seen Mar 01, 2026 · Last updated May 02, 2026 · Updated 9 times
Summary
This study tests whether giving a strong chemotherapy directly to the liver, followed by standard cancer pills or infusions, works better than standard treatment alone for breast cancer that has spread mainly to the liver. About 90 adults with HER2-negative breast cancer will take part. The goal is to control the disease in the liver and improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER IN THE LIVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
-
Ohio State University, Stefanie Spielman Comprehensive Breast Center
RECRUITINGColumbus, Ohio, 43212, United States
Conditions
Explore the condition pages connected to this study.